Remove Leads Remove Networking Remove Pharmaceutical products Remove White Paper
article thumbnail

Inflationary storm clouds will continue to buffet global pharma industry in 2023

Pharmaceutical Technology

The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. However, a looming risk on the horizon in 2023 is that the economic pain may produce downstream effects on global pharmaceutical supply chain networks.

Pharma 64
article thumbnail

Inflationary storm clouds will continue to buffet global pharma industry in 2023

Pharmaceutical Technology

The resulting reduced profit margins could lead to further supply chain constraints of some loss-making products in certain markets. However, a looming risk on the horizon in 2023 is that the economic pain may produce downstream effects on global pharmaceutical supply chain networks.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The impact of climate change on the pharma supply chain

Pharmaceutical Technology

And delays in the supply chain, even for short periods of time can potentially affect the efficacy of medicines, lead to longer-term supply bottlenecks, and ultimately prevent people from getting access to the critical medicines they need. Pharma manufacturing can also be affected by extreme weather events, such as storms.

Pharma 142
article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

Digitalisation of previously manual processes heralds ground-breaking progress for the pharma supply chain, leading to better data integration and integrity, superior visibility and faster delivery processes through validated data. Controlant is a global leader in the digital transformation of pharma supply chains.

Pharma 52